Virginia Retirement Systems’s NewAmsterdam Pharma NAMS Stock Holding History

Virginia Retirement Systems’s Portfolio NAMS Stock Details NAMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$253K	Buy	+7,200	New	+$262K	﹤0.01%	877

Other funds holding NAMS

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Virginia Retirement Systems's NAMS Position: Q4 2025 in Review

Virginia Retirement Systems opened a new position in NewAmsterdam Pharma (NAMS) in Q4 2025: 7,200 shares worth $253K. The stake represents ﹤0.01% of the portfolio and ranks #877 among its holdings.

186 funds tracked by Wall St. Rank hold NAMS as of Q4 2025.

Virginia Retirement Systems held 7,200 shares of NewAmsterdam Pharma worth $253K as of Q4 2025.
NewAmsterdam Pharma was a new Virginia Retirement Systems position in Q4 2025.
NewAmsterdam Pharma made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #877 holding.
186 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.